NKGen Biotech, Inc.
NKGN
$0.02
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -545.80% | 141.01% | -198.92% | 83.99% | -1.29% |
| Total Depreciation and Amortization | -0.30% | 1.84% | 0.00% | 8.67% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 298.85% | -229.38% | 869.35% | -105.02% | -8.70% |
| Change in Net Operating Assets | -262.17% | 1,239.02% | -94.59% | 60.55% | 43.86% |
| Cash from Operations | -78.51% | 35.07% | -48.71% | 41.86% | -52.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.88% | -13.33% | -- | -- | -- |
| Cash from Investing | 5.88% | -13.33% | -142.86% | 294.44% | -- |
| Total Debt Issued | 77.13% | -66.93% | 462.55% | 2,356.67% | -99.53% |
| Total Debt Repaid | 58.46% | -- | -- | -- | -- |
| Issuance of Common Stock | 790.54% | -- | -- | -- | -99.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -103.99% | 227.94% | -188.16% | 261.96% | 32.82% |
| Cash from Financing | 82.38% | -36.95% | 51.21% | 322.24% | -114.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.83% | -304.44% | 462.50% | 100.09% | -215.81% |